Bone Therapeutics Treats First Patients in Phase III Knee Osteoarthritis Study

Knee Pain

Bone Therapeutics treated the first patients in a pivotal JTA-004 Phase III clinical study in Hong Kong. Tweny other clinical trial sites in Europe are expected to resume recruitment activities as COVID-19 lockdown measures are gradually lifted.

The controlled, randomized, double-blind trial will evaluate the potential of a single,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us